Press Release

CD BIOSCIENCES LAUNCHES FLUORESCENCE CORRELATION SPECTROSCOPY



CD BioSciences has recently announced the launch of Fluorescence Correlation Spectroscopy.

FOR IMMEDIATE RELEASE

26/04/2023

CD BioSciences, a US-based biotechnology company focusing on the development of imaging technology, has recently announced the launch of Fluorescence Correlation Spectroscopy to assist researchers in detecting molecular concentrations, hydrodynamic radii, diffusion dynamics and interactions of different biomolecules.

Fluorescence correlation spectroscopy (FCS) is a technique for measuring fluorescence fluctuations in molecular systems. It has been widely employed in biomedicine, biophysics, chemistry and other fields. FCS can measure fluctuations in fluorescence intensity caused by Brownian motion or chemical reactions in a small volume and quantitatively evaluate the concentrations, diffusion coefficients and interactions of fluorescent molecules in simple artificial models or in living cells.

In an equilibrium solution, the number of fluorescent molecules in the microregion is determined by the concentration of fluorescent molecules in the solution and the volume of the region. When fluorescent molecules diffuse due to Brownian motion or intermolecular chemical reactions, the fluorescence intensity of the microregion will change over time and fluorescence fluctuations will occur. FCS then utilizes this phenomenon for analysis and detection.

FCS is usually performed in a confocal system where the fluorescence emitted by fluorescently labeled molecules in the observation volume is collected by the same objective and propagates opposite the excitation/dissipation light direction. After passing through a long-pass dichroic mirror, the fluorescence is focused through a pinhole onto an avalanche photodiode. The fluorescence emitted in the out-of-focus region is rejected by the pinhole and it does not reach the detector. Thus, the pinhole reduces the axial extension of the viewing volume. This restricted observation volume significantly improves the signal-to-noise ratio and also reduces the measurement time to obtain a good correlation curve.

CD Biosciences has been developing fluorescent probes and imaging technologies for many years. The company now offers various types of FCS, such as Dual-color FCCS, Multi-focus FCS, Scanning FCS, Focus-reduced FCS, and STED-FCS, which can be employed to detect molecular concentrations, hydrodynamic radii, diffusion dynamics and interactions of different biomolecules.

Applications

Nucleic acid breakage and nucleic acid hybridization
Binding equilibrium of drugs and other low molecular weight ligands
Lateral separation of lipids in bilayer membranes
Protein-protein interactions
Aggregation of membrane-bound receptors

Advantages

High spatial and temporal resolution, short analysis time and high sensitivity
Measure the spatial and temporal correlation of individual molecules with themselves
Avoids artifacts caused by photobleaching and membrane motion

CD BioSciences possesses a professional team with extensive working experience in the imaging field. Its team can provide customers with personalized imaging services that meet research needs in the fields of biology, microbiology, medicine, and food.

For customers interested in learning more about Fluorescence Correlation Spectroscopy, please visit CD BioSciences at https://www.bioimagingtech.com/.

* For Research Use Only. Not for therapeutic or diagnostic applications.

About CD BioSciences

CD BioSciences is a biotechnology company committed to the development of imaging technology for many years. Its scientists can utilize high-content imaging, nanoparticle imaging, imaging flow cytometry, time-lapse imaging, and other techniques to image cell structure, cell migration, cell proliferation, pathogen infection mechanisms, and interactions between protein molecules. In addition, the team is capable of applying powerful analytical software to capture images of cellular structure, subcellular, or tissues for useful information.

Tags:
CD BioSciences  |  Fluorescence Correlation Spectro  |  

---

Organisation Profile:
CD BioSciences is a trusted research product supplier and CRO based in New York. With high-quality reagents and comprehensive services, CD BioSciences is the one-stop shop devoted to researchers making advancements in signaling pathway studies.






Press release contact details for CD BioSciences

NameCD BioSciences
Tel
Fax
Email
Websitehttps://www.cd-biosciences.com/
OrganisationCD BioSciences
Address
Town
County
Postcode




Other press releases from CD BioSciences

CD BioSciences Introduces New Solutions to Support Cell Death Studies
CD BioSciences Launches Scaffold-Based Technologies for 3D Cell Culture
CD BioSciences Launches Hyperspectral Imaging Technology for Food Safety
CD BioSciences Introduces New Cell Death Solutions to Facilitate Research
CD BioSciences Launches Fluorescence Correlation Spectroscopy
CD BioSciences Introduces Various Solutions for Studying Apoptotic Cell Death
CD BioSciences Launches Nanoparticles Imaging Technology for Scientists
CD BioSciences Introduces Multiple Solutions for Type II Cell Death Research
CD BioSciences Launches New Time-Lapse Imaging Services for Scientists
CD BioSciences Launches New Solutions for Microautophagy Research
CD BioSciences Announces New Immunofluorescence-Based Services
CD BioSciences Launches New Solutions for Type III Cell Death Research
CD BioSciences Launches New Super-Resolution Imaging Technology for Biomedical Research
CD BioSciences Announces New Research Solutions on Mitotic Catastrophe
CD BioSciences Announces New Single Molecule Fluorescence Imaging Technology
CD BioSciences Introduces New Metabolic Homeostasis Research Solutions
CD BioSciences Launches New Services to Study Catabolism in Diabetes
CD BioSciences Launches New 3D Tissue Imaging Services
HighRun DataScience Launches Data Science Platform for Global Customers
CD BioSciences Announces New Solutions for Studying Anabolism
CD Biosciences Introduces 3D Image Analysis Services For Bioimaging Research
CD BioSciences Expands Portfolio with Wide Range of Embedding Resins and Kits for Electron and Light Microscopy
CD BioSciences Announces New Solutions for Glucose Homeostasis Research
CD Biosciences Announces Expanded Capabilities for Mechanistic Target of Rapamycin Research in Diabetes and Metabolism
CD Biosciences Launches Substrate-Chromogens for Immunohistochemistry
CD BioSciences Launches New Range of In Vivo Imaging Reagents for Scientific Research
CD BioSciences Introduces IHC Ancillaries for Enhanced Research and Diagnostics
CD BioSciences Announces Comprehensive Range of Nervous System Tissue Microarrays

Disclaimer:
Issuers of the press releases are solely responsible for the content of their press releases. Connect2business.co.uk cannot be held liable for the content posted by others to this website.